Airwave Compression Therapy to Prevent Breast Cancer-related Lymphedema
NCT ID: NCT06495034
Last Updated: 2024-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
132 participants
INTERVENTIONAL
2023-07-01
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistance Training to Prevent Lymphedema After Breast Cancer Surgery Randomized Controlled Study
NCT06459245
Comparing Level 1 Compression Sleeves With Routine Care in Preventing Breast Cancer-related Arm Lymphedema
NCT06095323
Treatment of Breast Cancer-related Lymphoedema
NCT03992508
Study of the Change of Breast Cancer Patients' Upper Limb Lymphatic Drainage Pathway After Operation
NCT02691624
Supermicrosurgical Lymphaticovenous Anastomosis for Prevention of Upper Limb Lymphedema
NCT07026292
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
standard care: health education and routine functional exercise
standard care: health education and routine functional exercise
standard care: health education and routine functional exercise
experimental group
1. standard care: health education and routine functional exercise;
2. airwave compression therapy
airwave compression therapy
Airwave compression therapy was given to patients after breast cancer surgery to treat the ipsilateral upper limb
standard care: health education and routine functional exercise
standard care: health education and routine functional exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
airwave compression therapy
Airwave compression therapy was given to patients after breast cancer surgery to treat the ipsilateral upper limb
standard care: health education and routine functional exercise
standard care: health education and routine functional exercise
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female, ≥18 years old and ≤70 years old at the time of signing the ICF;
* Patients with unilateral breast cancer diagnosed by histopathology or cytology;
* No distant metastasis;
* To undergo unilateral axillary sentinel lymph node biopsy or unilateral axillary lymph node dissection;
* Have not received any treatment for arm lymphedema;
* No lymphangitis and other infections.
Exclusion Criteria
* Patients with second primary tumor;
* Contraindication to airwave compression therapy: Acute venous thrombosis; Acute inflammatory skin disease; Erysipelas; Arrhythmia; Pulmonary edema; Unstable hypertension; People with artificial pacemakers; Deep thrombophlebitis;
* Have a history of mental illness or other reasons can not cooperate with treatment;
* Embolism, cardiogenic edema, hepatogenic edema and the history of upper limb trauma and other related complications;
* Patients using any medication that affects fluid or electrolyte balance.
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shantou Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Si-Qi Qiu
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shantou Central Hospital
Shantou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ShantouCH003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.